Research & Development: Page 86
-
PharmaVoice Team/PharmaVoice
New Techniques Drive Patient Enrollment for Trials
New Techniques Drive Patient Enrollment for Trials The number of clinical trials for new drugs continues to grow, increasing the competition for patients. IMS data show that new drug-discovery technologies are fueling record worldwide growth. There are more than 13,000 studies projected for 20...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Clinical Services: Managing the Moving Parts
Clinical Services: Managing the Moving Parts By Taren Grom, Editor The Cost of Doing Business The cost of drug development remains on the rise, with most estimates showing that the clinical-trials stage alone accounts for 40% of all costs related to R&D. Our Forum experts discuss...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Stock via Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Table of Contents
Letter from the Editor The Forum Clinical Services: Managing the Moving Parts — The clinical-research process is complex and requires integrated, sophisticated processes, technologies, and management to reduce costs, improve timelines, and produce safe therapeutics. Company Listing by Topic of In...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Integration and Workflow Issues for Clinical-Services Providers to Ensure Smooth Trials
Integration and Workflow Issues for Clinical-Services Providers to Ensure Smooth Trials Mary T. Stefanzick, Associate Director of Operations An ongoing imperative in clinical research for pharma and biotech companies is to accelerate processes and timelines to get new products to market ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Overcoming Poor Quality Data for ECG Collection
Overcoming Poor Quality Data for ECG Collection Timothy Callahan, Ph.D., Chief Scientific Officer The ICH E14 has become the touchstone guideline when designing and implementing Thorough QT (TQT) trials. Even protocols that are not designed primarily as a QT trial often use recommendations fr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Using Advanced Simulation in Clinical Operations
Using Advanced Simulation in Clinical Operations Jack Porter, President and CEO, ePharmamindshare The introduction of supercomputers and sophisticated simulation software for planning and optimizing clinical trials is rapidly becoming established in the pharmaceutical industry. These simulati...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Benefits of Using an EDC System to Collect and Reconcile Serious Adverse Events
Benefits of Using an EDC System to Collect and Reconcile Serious Adverse Events Gary Tyson, Senior VP, Clinical Development Practice Marybeth Lynch, Associate Practice Executive, Clinical Development Practice Collecting and reconciling adverse events (AEs) and serious adverse events (SAEs)...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Pediatric Patient Retention: It's not Child's Play
Pediatric Patient Retention: It’s not Child’s Play Elizabeth Moench President and CEO Samantha Cook Pediatric Account Manager John Hartigan VP, Creative and Editorial Services The Ever-Changing Population A universal challenge of conducting long-term pediatric studies is the constant ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The ROI of ePRO
The ROI of ePRO Phil Lee, President and CEO The power of listening to the patient voice by using e-diary systems to collect the best PRO data possible and manage subject enrollment, compliance, and safety in real time may still be overlooked by some sponsors, who are hesitant to switch to eP...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
rug development is a lengthy, complex, and expensive process, requiring hundreds of moving parts to act in concert to bring a therapeutic agent safely to market. According to the Association of Clinical Research Organizations, bringing a new drug or medical device to market can take 20 years an...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Pharma Solutions and Services: The Wider Landscape
Pharma Solutions and Services: The Wider Landscape by Jeffrey Smith, Managing Director Given the central role of pharmaceuticals in the single largest U.S. economic sector, and the extent to which the pharma industry is information-driven, the already very act...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Clinical Resource Management: New Strategy Minimizes Co-Employment Risk
Clinical Resource Management: New Strategy Minimizes Co-Employment Risk inVentiv Clinical Solutions LLC The approval of a new drug candidate is typically impacted by hundreds, if not thousands, of people during the development cycle. Without talented people, the clinical development plan is...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
An Emissary for Patients -- Kathy Giusti
An Emissary for Patients — Kathy Giusti Nonprofit and successful business are terms seldom spoken together, yet demonstrably this is the way to achieve results. Make no mistake, uniting these two concepts takes a truly special individual. Kathy Giusti, founder and CEO of the Multiple Myeloma Rese...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Last Word
ACRO’s Chair Jeffrey McMullen In December 2006, Jeffrey McMullen, president and CEO of PharmaNet Development Group, was elected chair of the Association of Clinical Research Organizations (ACRO), Washington, D.C. (For more information about ACRO, visit acrohealth.org.) He is joined on the board b...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
ACRP conference Record Attendance The 2007 ACRP Global Conference and Exposition in Seattle drew more than 2,700 attendees, making this year’s event one of the most successful for the organization. The association is positioned as the primary resource for clinical research professionals in the ph...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Managed Markets: Pharmacists
Playing a Pivotal Role Experts believe that pharmacists are ideally positioned to help patients better manage their drug therapies, as such they play a pivotal role helping seniors navigate the new Medicare Part D prescription drug plan. By Denise Myshko Pharmacists across the United States conti...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies HealthCentral Introduces Online Network The HealthCentral Network (THCN) has relaunched its network of sites to better meet the needs of today’s patients. Each Website offers interactive medical information targeted to a specific ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Zhi Hong GSK Appoints Head, Infectious-Diseases Research Center Healthcare company GlaxoSmithKline, Philadelphia, has appointed Zhi Hong, Ph.D., to lead a newly organized research unit dedicated to discovering therapies for infectious diseases. Dr. Hong heads the Infectious Diseas...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Project Teams Can Benefit from Better Data The one thing we see more than anything else, regardless of company size, is a lack of trustworthy data. — Karen Briegs, Director, 3C Company Embracing Business Intelligence It was so interesting to read the thoughts of the various project managers on th...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
On the Calendar June 2007 June 17-21 DIA 43rd Annual Meeting Georgia World Congress Center, Atlanta PharmaVOICE is exhibiting at this event. For more information, contact Drug Information Association at 215-442-6100, e-mail [email protected], or visit diahome.org. June 18-19 3rd Annual Medical Devi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Strategic Patient Adherence Awards
The SPA Awards cosponsored by CBI and PharmaVOICE were presented at the 6th Annual Forum on Patient Compliance, Adherence and Persistency. 6th annual Forum on patient compliance, adherence and persistency Informative presentations, executive thought leadership, and a prestigious awards ceremony p...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies TGaS Advisors Offers Collaborative Benchmarking Services for Pharmaceutical Companies Pharmastance operational resource lets companies learn where they stand. TGaS Advisors has launched the Pharmastance family of benchmarks. These collabora...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Commanders & Chiefs
These champions of industry demonstrate their commitment to their employees, their companies, and their communities by setting high personal and corporate standards. Mehmood Khan, M.D. Mehmood Khan, M.D.’s favorite quote is from Michelangelo: Ancora Imparo, which translates into “I am still learn...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Nanotech Comes of Age
By Kim Ribbink The once futuristic science of nanotechnology has come of age and branched into a broad spectrum of applications. Among these is nanomedicine: medicinal intervention at the molecular level for curing disease, repairing damaged tissue, and monitoring biological systems. The National...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Section 199 Deduction for Qualified Production Activity Income
In October of 2004, the U.S. Congress and President Bush signed into law the American Jobs Creation Act of 2004. The Act is the first major corporate tax act in over a decade. A key provision of the Act is a new domestic manufacturing deduction designed to improve the global competitiveness of U....
By PharmaVoice Team • Jan. 2, 2008
Previous
